Contains viable, selected strains of human adenovirus type 4 and human adenovirus type 7 prepared in human-diploid fibroblast cell cultures (strain wi-38); virus strains have not been attenuated; cells are grown and the virus growth maintained in dulbecco's modified eagle's medium, fetal bovine serum, and sodium bicarbonate; approved for use in military populations 17-50 years of age; indicated for active immunization for the prevention of febrile acute respiratory disease caused by adenovirus type 4 and type 7; carton consists of one bottle of 100 tablets adenovirus type 4 (ndc 51285-174-02) and one bottle of 100 tablets adenovirus type 7 (ndc 51285-175-02); store refrigerated between 2-8 degrees c (35-46 degrees f); do not freeze; keep bottle tightly closed and protect from moisture; do not remove desiccant canister from bottle; prescription only; for oral administration; dosage: one tablet of adenovirus type 4 component and one tablet of adenovirus type 7 component
NSN 5835-01-408-7576
NSN 6145-01-054-7463
NSN 6240-01-350-3533
NSN 5945-01-190-4785
NSN 6620-01-296-9803
NSN 5950-00-912-1795
NSN 5945-01-392-0871
NSN 5915-01-097-8451
NSN 6320-01-039-5891
NSN 5965-01-347-5878
NSN 5985-00-259-4906
NSN 5915-00-894-3825